APA (7th ed.) Citation

Liu, Y., Jeng, W., Peng, C., Chien, R., & Liaw, Y. (2024). Higher end‐of‐treatment HBsAg levels is associated with later onset but not severe relapse in HBeAg‐negative chronic hepatitis B patients stopping antivirals. Alimentary Pharmacology & Therapeutics, 59(6), 762. https://doi.org/10.1111/apt.17880

Chicago Style (17th ed.) Citation

Liu, Yen‐Chun, Wen‐Juei Jeng, Chien‐Wei Peng, Rong‐Nan Chien, and Yun‐Fan Liaw. "Higher End‐of‐treatment HBsAg Levels Is Associated with Later Onset but Not Severe Relapse in HBeAg‐negative Chronic Hepatitis B Patients Stopping Antivirals." Alimentary Pharmacology & Therapeutics 59, no. 6 (2024): 762. https://doi.org/10.1111/apt.17880.

MLA (9th ed.) Citation

Liu, Yen‐Chun, et al. "Higher End‐of‐treatment HBsAg Levels Is Associated with Later Onset but Not Severe Relapse in HBeAg‐negative Chronic Hepatitis B Patients Stopping Antivirals." Alimentary Pharmacology & Therapeutics, vol. 59, no. 6, 2024, p. 762, https://doi.org/10.1111/apt.17880.